| 16/0104/13-S |
60382 |
Actilyse 20 mg |
plv iio 2x20 mg+2x20 ml solv. (liek.inj.skl.+liek.inj.skl.) |
BOE |
|
| 16/0104/13-S |
93649 |
Actilyse 20 mg |
plv iio 1x20 mg+1x20 ml solv. (liek.inj.skl.+liek.inj.skl.) |
BOE |
|
| 16/0414/92-CS |
60383 |
Actilyse 50 mg |
plv iio 2x50 mg+2x50 ml solv. (liek.inj.skl.+liek.inj.skl.) |
BOE |
|
| 16/0414/92-CS |
93650 |
Actilyse 50 mg |
plv iio 1x50 mg+1x50 ml solv. (liek.inj.skl.+liek.inj.skl.) |
BOE |
|
| 16/0362/00-S |
57364 |
Aggrenox, 200/25 mg tvrdé kapsuly s riadeným uvo??ovaním |
cps mdd 60x200 mg/25 mg (liek.PP) |
BOE |
|
| 16/0362/00-S |
57363 |
Aggrenox, 200/25 mg tvrdé kapsuly s riadeným uvo??ovaním |
cps mdd 30x200 mg/25 mg (liek.PP) |
BOE |
|
| EU/1/05/315/002 |
80100 |
Aptivus 100 mg/ml perorálny roztok |
sol por 1x95 ml (100 mg/1 ml) ( f?.skl.) |
BOE |
|
| EU/1/05/315/001 |
97766 |
Aptivus 250 mg mäkké kapsuly |
cps mol 120x250 mg (f?.HDPE) |
BOE |
|
| 14/0176/79-CS |
32992 |
ATROVENT N 20 µg |
sol inh 1x10 ml/200 dávok (obal Al tlakový) |
BOE |
|
| 14/0121/83-CS |
15722 |
BERODUAL N |
sol inh 1x10 ml/200 dávok (obal kovový) |
BOE |
|
| EU/1/17/1240/004 |
6275C |
Cyltezo 40 mg injek?ný roztok v naplnenej injek?nej strieka?ke |
sol inj 6x40 mg (striek.inj.napl.skl.) |
BOE |
10.11.2022 |
| EU/1/17/1240/003 |
6274C |
Cyltezo 40 mg injek?ný roztok v naplnenej injek?nej strieka?ke |
sol inj 4x40 mg (striek.inj.napl.skl.) |
BOE |
10.11.2022 |
| EU/1/17/1240/002 |
6273C |
Cyltezo 40 mg injek?ný roztok v naplnenej injek?nej strieka?ke |
sol inj 2x40 mg (striek.inj.napl.skl.) |
BOE |
10.11.2022 |
| EU/1/17/1240/001 |
6272C |
Cyltezo 40 mg injek?ný roztok v naplnenej injek?nej strieka?ke |
sol inj 1x40 mg (striek.inj.napl.skl.) |
BOE |
10.11.2022 |
| EU/1/17/1240/008 |
6279C |
Cyltezo 40 mg injek?ný roztok v naplnenom pere |
sol inj 6x40 mg (striek.inj.napl.skl. v pere) |
BOE |
10.11.2022 |
| EU/1/17/1240/007 |
6278C |
Cyltezo 40 mg injek?ný roztok v naplnenom pere |
sol inj 4x40 mg (striek.inj.napl.skl. v pere) |
BOE |
10.11.2022 |
| EU/1/17/1240/006 |
6277C |
Cyltezo 40 mg injek?ný roztok v naplnenom pere |
sol inj 2x40 mg (striek.inj.napl.skl. v pere) |
BOE |
10.11.2022 |
| EU/1/17/1240/005 |
6276C |
Cyltezo 40 mg injek?ný roztok v naplnenom pere |
sol inj 1x40 mg (striek.inj.napl.skl. v pere) |
BOE |
10.11.2022 |
| EU/1/13/879/003 |
7594A |
GIOTRIF 20 mg filmom obalené tablety |
tbl flm 28x1x20 mg (blis.PVC/PVDC-perf.) |
BOE |
|
| EU/1/13/879/002 |
7593A |
GIOTRIF 20 mg filmom obalené tablety |
tbl flm 14x1x20 mg (blis.PVC/PVDC-perf.) |
BOE |
|
| EU/1/13/879/001 |
7592A |
GIOTRIF 20 mg filmom obalené tablety |
tbl flm 7x1x20 mg (blis.PVC/PVDC-perf.) |
BOE |
|
| EU/1/13/879/006 |
7597A |
GIOTRIF 30 mg filmom obalené tablety |
tbl flm 28x1x30 mg (blis.PVC/PVDC-perf.) |
BOE |
|
| EU/1/13/879/005 |
7596A |
GIOTRIF 30 mg filmom obalené tablety |
tbl flm 14x1x30 mg (blis.PVC/PVDC-perf.) |
BOE |
|
| EU/1/13/879/004 |
7595A |
GIOTRIF 30 mg filmom obalené tablety |
tbl flm 7x1x30 mg (blis.PVC/PVDC-perf.) |
BOE |
|
| EU/1/13/879/009 |
7600A |
GIOTRIF 40 mg filmom obalené tablety |
tbl flm 28x1x40 mg (blis.PVC/PVDC-perf.) |
BOE |
|
| EU/1/13/879/008 |
7599A |
GIOTRIF 40 mg filmom obalené tablety |
tbl flm 14x1x40 mg (blis.PVC/PVDC-perf.) |
BOE |
|
| EU/1/13/879/007 |
7598A |
GIOTRIF 40 mg filmom obalené tablety |
tbl flm 7x1x40 mg (blis.PVC/PVDC-perf.) |
BOE |
|
| EU/1/13/879/012 |
7603A |
GIOTRIF 50 mg filmom obalené tablety |
tbl flm 28x1x50 mg (blis.PVC/PVDC-perf.) |
BOE |
|
| EU/1/13/879/011 |
7602A |
GIOTRIF 50 mg filmom obalené tablety |
tbl flm 14x1x50 mg (blis.PVC/PVDC-perf.) |
BOE |
|
| EU/1/13/879/010 |
7601A |
GIOTRIF 50 mg filmom obalené tablety |
tbl flm 7x1x50 mg (blis.PVC/PVDC-perf.) |
BOE |
|
| EU/1/16/1146/009 |
1963C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 100x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/008 |
1962C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 90x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/007 |
1961C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 70x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/006 |
1960C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 60x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/005 |
1959C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 30x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/004 |
1958C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 28x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/003 |
1957C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 14x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/002 |
1956C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 10x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/001 |
1955C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 7x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/018 |
1973C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 100x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/017 |
1972C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 90x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/016 |
1971C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 70x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/015 |
1970C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 60x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/014 |
1969C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 30x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/013 |
1968C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 28x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/012 |
1967C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 14x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/011 |
1965C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 10x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/010 |
1964C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 7x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/14/930/018 |
0698B |
Jardiance 10 mg filmom obalené tablety |
tbl flm 100x1x10 mg (blis.PVC/Al - perf.) |
BOE |
22.05.2019 |
| EU/1/14/930/017 |
0697B |
Jardiance 10 mg filmom obalené tablety |
tbl flm 90x1x10 mg (blis.PVC/Al - perf.) |
BOE |
22.05.2019 |
1
